Where does Adienne Pharma &biotech SA rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Adienne Pharma &biotech SA ranks #22,127 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Adienne Pharma &biotech SA hold?

Adienne Pharma &biotech SA holds 12 US utility patents granted between 2018 and 2025, spanning 9 technology areas.

What is Adienne Pharma &biotech SA's Innovation Score?

Adienne Pharma &biotech SA has an Innovation Score of 30.8 out of 100 (36th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Adienne Pharma &biotech SA's patent grant rate increasing or decreasing?

Adienne Pharma &biotech SA's recent grant velocity is -43% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Adienne Pharma &biotech SA's patents?

Adienne Pharma &biotech SA's patents average 13.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Adienne Pharma &biotech SA patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Adienne Pharma &biotech SA

Q: What technology areas does Adienne Pharma &biotech SA focus on?

Adienne Pharma &biotech SA's top technology area is A61J (Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices FOR Administering Food OR Medicines ORALLY; Baby COMFORTERS; Devices FOR Receiving Spittle) with 10 patents, ranking #92 of 903 assignees active in that subclass. Grants appear in 9 CPC subclasses total.

USPTO PatentsView assignee record - 12 granted patents across 9 technology areas, recorded in grant years 2018–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61J (Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices ).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Adienne ranks #22,127 of 49,997 tracked US assignees by granted-patent volume, with 12 patents across 9 technology areas.

#22,127
of 49,997 US assignees by volume: 36th percentile
by Innovation Score (30.8/100): 13.3
avg claims per patent: -43%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R22127 · Foreign Corporation #22,127 · 12 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 12 grants
MID-PACK #22,127/49,997
PHOTO-FINISH Ablerex
CPC-NARROW A61J · 9 areas
INNOV-THIN 30.8/100
CLAIMS-RICH 13.3 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -43% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Ablerex Electronics Co., Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Adienne’s 30.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.9 pts (29%) Velocity 3.3 pts (11%) Breadth 10.6 pts (34%) Claim depth 8.0 pts (26%)

Qualcomm Incorporated · highest

85
Allen-vanguard · near

31
Petram · near

31
Savage Arms · near

31
Adienne Pharma… · this assignee

31
Vanderbilt Chemicals · near

31
3D Lighting… · lowest

7

What this shows Adienne's Innovation Score is 30.8/100 (36th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Adienne?

Each dot is one of Adienne’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Adienne’s own 13.3 claims/patent is at or below the 15.2 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Adienne vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Adienne's grants concentrate

Adienne Pharma &biotech SA is a focused PatentsView assignee: 9 CPC subclasses with 83.3% of grants classified under A61J (Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices ). Peak complete grant year is 2019 (5 grants) versus a trough of 1 in 2021. By volume, Adienne sits between Ablerex Electronics Co., Ltd. and AF Chemicals, LLC.

Adienne's three-year grant acceleration

Adienne Pharma &biotech SA shows 3 grants in 2022–2024 against only 6 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Ablerex

12
ABU Dhabi Polymer…

12
ABU Dhabi Polymer…

12
Accusonus

12
Adtran Networks SE

12
Aduro Biotech Hol…

12
Advanced Internat…

12
AF Chemicals

12
Adienne Pharma &b… ◀

12

What this shows Adienne holds 12 patents at rank #22,119, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Adienne

By rank, the assignees closest to #22,119 in granted patent volume.

Leaders in A61J (Containers Specially Adapted FOR Medical OR Pharmaceutica…)

Other assignees with the most granted patents in Adienne's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Adienne, neither rank-band nor same-CPC leaders (those blocks stay above). In A61J (Containers Specially Adapted FOR Medical OR Pharmaceutica…), Adienne ranks #92 of 903 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (31 here).

Vanderbilt Chemicals, LLC 31 Petram Technologies, Inc. 31 Allen-vanguard Corporation 31 Savage Arms, Inc. 31

Adienne's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

31 36th percentile higher than 36% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2018–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table

Adienne Pharma &biotech SA patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2018	2	16.7%
2019	5	41.7%
2021	1	8.3%
2022	1	8.3%
2023	1	8.3%
2024	1	8.3%
2025partial year	1	8.3%

Which technologies does Adienne Pharma &biotech SA patent most?

A61J - Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices FOR Administering Food OR Medicines ORALLY; Baby COMFORTERS; Devices FOR Receiving Spittle 10

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 9

B65D - Containers FOR Storage OR Transport OF Articles OR Materials, e.g. Bags, Barrels, Bottles, Boxes, Cans, Cartons, Crates, Drums, Jars, Tanks, Hoppers, Forwarding CONTAINERS; Accessories, Closures, OR Fittings THEREFOR; Packaging ELEMENTS; Packages 8

F26B - Drying Solid Materials OR Objects BY Removing Liquid Therefrom 7

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 5

C08L - Compositions OF Macromolecular Compounds 4

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 1

C07K - Peptides 1

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 1

Top 9 of 9 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Adienne Pharma &biotech SA's patent record in context - here's where to go next.

Adienne Pharma &biotech SA's lead technology class is A61J (Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices ), 83.3% of its portfolio - see every assignee active in that class. Explore A61J
Ranked #22,127 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Adienne Pharma &biotech SA against Ablerex Electronics Co., Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 30.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.